@gossamerbio.com
video of the thread
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Gossamer Bio is a clinical-stage biopharmaceutical company with a clear vision, strong connections, and a commitment to innovative solutions. Our focus is on the development and commercialization of seralutinib, our lead clinical product candidate, for the treatment of pulmonary arterial hypertension (PAH). With the aim of enhancing the lives of patients suffering from this condition, we strive to be an industry leader in the field of pulmonary hypertension.
Our pipeline includes seralutinib (GB002), an inhaled PDGFR, CSF1R, c-KIT inhibitor, with Phase 3 planned. We are dedicated to delivering effective treatments and making a positive impact. At Gossamer Bio, we believe in transparency and collaboration.
We provide valuable information about the underlying causes of PAH and offer resources for patients and healthcare professionals. Our website features a video that gives an overview of who we are and what we do. Join us in our pursuit of innovation and patient-centric solutions.
Together, we can make a difference in the lives of those affected by pulmonary arterial hypertension
Company Type
Privately Held
Company Size
51-200
Year Founded
2017
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories